Supreme Court Won't Mull Hospira's Duty To Supply Drug

Law360, New York (October 15, 2013, 5:55 PM EDT) -- The U.S. Supreme Court on Tuesday declined to review the Eleventh Circuit's ruling that Hospira Inc. had no special duty to a proposed class of patients to supply an injectable form of vitamin A, even if it was the drug's only manufacturer.

The high court denied a petition for certiorari filed in September by Jennifer Lacognata, who claims she needs the drug Aquasol A because she cannot metabolize the vitamin A content in her food. Hospira is the only company approved to sell injectable vitamin A...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.